Dr. Katia Mangano graduated in Pharmaceutical Chemistry and Technology at the University of Catania and obtained the qualification for the profession of Pharmacist in 2001 and the PhD in Microbiological Disciplines in 2004. Dr. Katia Mangano has been and is auditor and is part of the editorial board of several magazines. Since 2000 Katia Mangano has been engaged in research in immunology, immunopharmacology, autoimmunalogy and experimental oncology at the Laboratory of Immunopathology and Translational Immunopharmacology, Department of Biomedical and Biotechnological Sciences, University of Catania, directed by Prof. by Ferdinando Nicoletti. Dr. Katia Mangano's research is focused on the study of the pathogenetic mechanisms involved in the study of these diseases in animal models and on the evaluation of the effectiveness of new therapeutic approaches. This line of research has drawn collaborations with international pharmaceutical and biotech companies that have produced numerous publications and a significant contribution to the progress of the preclinical and clinical development of the compounds studied. The interest in a line of research also focused on the technology transfer and industrial enhancement of compounds is demonstrated by the patent activity obtained. The aforementioned collaboration, together with other national and international research groups, has produced 113 publications in international scientific journals reaching a h-index of 29.